Clarinex to join Claritin OTC?
Wellpoint files citizen petition April 15 to force an OTC switch of Schering-Plough's Clarinex. Desloratadine, approved Dec. 21, is an active metabolite of Schering's Claritin. Wellpoint previously forced FDA consideration of OTC switches for antihistamines Claritin, Zyrtec and Allegra through a citizen petition. FDA's Nonprescription Drugs Advisory Committee is meeting to discuss switching Claritin to OTC April 22...
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.